(CMRX) Chimerix - Performance 816% in 12m
Compare CMRX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
26.95%
#21 in Group
Rel. Strength
99.90%
#9 in Universe
Total Return 12m
816.01%
#3 in Group
Total Return 5y
454.55%
#5 in Group
P/E -
(?) Percentile in Group
P/E Forward 1.21
11th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -11.25%
68th Percentile in Group
12m Total Return: CMRX (816%) vs XBI (-8.9%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-18.4% | 8.88% | 153% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-9.36% | 20.2% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-0.68% | 26.4% | 40.5% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-13% | 8.75% | 36.7% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
| LONN SW Lonza |
-4.4% | 6.49% | 31% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-1.64% | 15.9% | 7.58% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-7.58% | -23.5% | -0.25% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-2.4% | 31.1% | -2.82% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: CMRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CMRX
| Total Return (including Dividends) | CMRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.71% | -11.88% | -5.89% |
| 3 Months | 122.40% | -16.10% | -12.45% |
| 12 Months | 816.01% | -8.91% | 6.72% |
| 5 Years | 454.55% | -19.71% | 101.06% |
| Trend Score (consistency of price movement) | CMRX | XBI | S&P 500 |
| 1 Month | 85.9% | -80.4% | -74.5% |
| 3 Months | 98.2% | -89.8% | -88.2% |
| 12 Months | 65.2% | -26.1% | 66.1% |
| 5 Years | -61.2% | -52.8% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #35 | 14.3% | 7.01% |
| 3 Month | #2 | 165% | 154% |
| 12 Month | #3 | 906% | 758% |
| 5 Years | #5 | 591% | 176% |
FAQs
Does CMRX Chimerix outperforms the market?
Yes,
over the last 12 months CMRX made 816.01%, while its related Sector, the SPDR S&P Biotech (XBI) made -8.91%.
Over the last 3 months CMRX made 122.40%, while XBI made -16.10%.
Over the last 3 months CMRX made 122.40%, while XBI made -16.10%.
Performance Comparison CMRX vs Indeces and Sectors
CMRX vs. Indices CMRX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.64% | 6.60% | 879% | 809% |
| US NASDAQ 100 | QQQ | 2.50% | 6.99% | 879% | 810% |
| US Dow Jones Industrial 30 | DIA | 2.81% | 6.53% | 878% | 811% |
| German DAX 40 | DAX | -3.72% | 10.1% | 862% | 798% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.93% | 8.21% | 876% | 810% |
| Hongkong Hang Seng | HSI | -2.65% | 10.5% | 877% | 800% |
| India NIFTY 50 | INDA | -2.73% | -4.06% | 876% | 813% |
| Brasil Bovespa | EWZ | -1.92% | 5.79% | 876% | 825% |
CMRX vs. Sectors CMRX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.39% | 6.37% | 870% | 802% |
| Consumer Discretionary | XLY | 2.51% | 4.63% | 876% | 807% |
| Consumer Staples | XLP | -1.66% | -2.49% | 869% | 802% |
| Energy | XLE | -3.08% | 10.8% | 878% | 826% |
| Financial | XLF | 0.27% | 5.22% | 871% | 797% |
| Health Care | XLV | 1.24% | 8.08% | 880% | 817% |
| Industrial | XLI | 0.52% | 5.41% | 879% | 811% |
| Materials | XLB | -0.08% | 7.36% | 886% | 824% |
| Real Estate | XLRE | -3.70% | 3.60% | 877% | 799% |
| Technology | XLK | 3.0% | 9.64% | 886% | 817% |
| Utilities | XLU | -1.67% | 1.13% | 873% | 792% |
| Aerospace & Defense | XAR | -0.05% | 0.67% | 869% | 792% |
| Biotech | XBI | -1.92% | 12.6% | 893% | 825% |
| Homebuilder | XHB | 0.69% | 7.55% | 897% | 825% |
| Retail | XRT | -0.06% | 2.82% | 883% | 820% |